• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊布替尼可逆性损害单核细胞向巨噬细胞的转变。

Monocyte-to-macrophage switch reversibly impaired by Ibrutinib.

作者信息

Ferrarini Isacco, Rigo Antonella, Montresor Alessio, Laudanna Carlo, Vinante Fabrizio

机构信息

Department of Medicine, University of Verona, Verona, Italy.

Section of Hematology, Cancer Research & Cell Biology Laboratory, University of Verona, Verona, Italy.

出版信息

Oncotarget. 2019 Mar 8;10(20):1943-1956. doi: 10.18632/oncotarget.26744.

DOI:10.18632/oncotarget.26744
PMID:30956776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6443008/
Abstract

Ibrutinib is increasingly adopted for treating lymphoid malignancies. While growing amounts of data pile up about Ibrutinib mechanism of action on neoplastic B cells, little is known about its impact on other immune cells. Here we investigated the effect of Ibrutinib on monocyte/macrophage functions. (1) Ibrutinib treatment of purified human monocytes affected both chemoattractant-triggered inside-out as well as integrin-mediated outside-in signaling events, thus provoking defective adhesion and spreading on purified integrin ligands, respectively. (2) In cell-culture experiments, Ibrutinib promoted a differentiation shift of monocytes to fibrocyte-like cells, characterized by the acquisition of a typical elongated cell morphology. Importantly, this clear-cut shape transition also occurred upon culturing monocytes with sera derived from Ibrutinib-treated patients, thus clearly suggesting that the drug concentrations achievable can generate the phenotypic shift. (3) Ibrutinib-induced fibrocyte-like cells showed adhesion deficiency, altered phagocytic properties, and, with respect to macrophages, they acquired the capability of generating larger amounts of reactive oxygen species, possibly displaying different metabolic activities. Taken together, our results indicate that Ibrutinib has profound effects on the monocyte/macrophage immunobiology. They may finally shed some light about the biological ground of several Ibrutinib-related toxicities.

摘要

伊布替尼越来越多地被用于治疗淋巴系统恶性肿瘤。尽管关于伊布替尼对肿瘤性B细胞作用机制的数据越来越多,但对于其对其他免疫细胞的影响却知之甚少。在此,我们研究了伊布替尼对单核细胞/巨噬细胞功能的影响。(1)用伊布替尼处理纯化的人单核细胞,会影响趋化因子触发的由内向外以及整合素介导的由外向内信号转导事件,从而分别导致在纯化的整合素配体上的黏附缺陷和铺展缺陷。(2)在细胞培养实验中,伊布替尼促使单核细胞向成纤维细胞样细胞分化转变,其特征是获得典型的细长细胞形态。重要的是,在用伊布替尼治疗的患者血清培养单核细胞时也会出现这种明显的形态转变,这清楚地表明可达到的药物浓度能够产生这种表型转变。(3)伊布替尼诱导的成纤维细胞样细胞表现出黏附缺陷、吞噬特性改变,并且相对于巨噬细胞,它们获得了产生大量活性氧的能力,可能显示出不同的代谢活性。综上所述,我们的结果表明伊布替尼对单核细胞/巨噬细胞免疫生物学有深远影响。它们最终可能会揭示一些与伊布替尼相关毒性的生物学基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b748/6443008/9b1719ba897f/oncotarget-10-1943-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b748/6443008/cec2689acd06/oncotarget-10-1943-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b748/6443008/2efc4876c84e/oncotarget-10-1943-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b748/6443008/c9225ad42360/oncotarget-10-1943-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b748/6443008/92a291c94f96/oncotarget-10-1943-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b748/6443008/adb321128e0e/oncotarget-10-1943-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b748/6443008/d7d0bb833a87/oncotarget-10-1943-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b748/6443008/9b1719ba897f/oncotarget-10-1943-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b748/6443008/cec2689acd06/oncotarget-10-1943-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b748/6443008/2efc4876c84e/oncotarget-10-1943-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b748/6443008/c9225ad42360/oncotarget-10-1943-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b748/6443008/92a291c94f96/oncotarget-10-1943-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b748/6443008/adb321128e0e/oncotarget-10-1943-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b748/6443008/d7d0bb833a87/oncotarget-10-1943-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b748/6443008/9b1719ba897f/oncotarget-10-1943-g007.jpg

相似文献

1
Monocyte-to-macrophage switch reversibly impaired by Ibrutinib.伊布替尼可逆性损害单核细胞向巨噬细胞的转变。
Oncotarget. 2019 Mar 8;10(20):1943-1956. doi: 10.18632/oncotarget.26744.
2
Comparative phenotypic and functional analyses of the effects of autologous plasma and recombinant human macrophage-colony stimulating factor (M-CSF) on porcine monocyte to macrophage differentiation.自体血浆和重组人巨噬细胞集落刺激因子(M-CSF)对猪单核细胞向巨噬细胞分化影响的比较表型和功能分析。
Vet Immunol Immunopathol. 2017 May;187:80-88. doi: 10.1016/j.vetimm.2017.04.006. Epub 2017 Apr 14.
3
EphA receptors and ephrin-A ligands are upregulated by monocytic differentiation/maturation and promote cell adhesion and protrusion formation in HL60 monocytes.EphA受体和ephrin-A配体在单核细胞分化/成熟过程中上调,并促进HL60单核细胞中的细胞黏附和突起形成。
BMC Cell Biol. 2017 Aug 29;18(1):28. doi: 10.1186/s12860-017-0144-x.
4
Platelet-derived CXCL12 regulates monocyte function, survival, differentiation into macrophages and foam cells through differential involvement of CXCR4-CXCR7.血小板衍生的CXCL12通过CXCR4 - CXCR7的不同参与来调节单核细胞功能、存活、向巨噬细胞和泡沫细胞的分化。
Cell Death Dis. 2015 Nov 19;6(11):e1989. doi: 10.1038/cddis.2015.233.
5
Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro.肿瘤细胞对单核细胞/巨噬细胞极化和功能的影响以及体外桑寄生亲脂性提取物的调节潜力。
BMC Complement Altern Med. 2015 Apr 24;15:130. doi: 10.1186/s12906-015-0650-3.
6
Monocyte/macrophage interactions with base and linear- and star-like PEG-modified PEG-poly(acrylic acid) co-polymers.单核细胞/巨噬细胞与碱基以及线性和星状聚乙二醇修饰的聚乙二醇-聚丙烯酸共聚物的相互作用。
J Biomed Mater Res A. 2003 Jul 1;66(1):62-78. doi: 10.1002/jbm.a.10516.
7
EphA2 promotes cell adhesion and spreading of monocyte and monocyte/macrophage cell lines on integrin ligand-coated surfaces.EphA2促进单核细胞以及单核细胞/巨噬细胞系细胞在整合素配体包被表面的黏附与铺展。
Cell Adh Migr. 2015;9(6):469-82. doi: 10.1080/19336918.2015.1107693.
8
Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon.细胞因子对人单核细胞体外分化的调节:巨噬细胞集落刺激因子诱导的肿瘤细胞毒性表型受γ干扰素的发育调控。
Cancer Res. 1993 Jun 1;53(11):2603-13.
9
Monocyte- and macrophage-mediated immune reactions against Eimeria bovis.单核细胞和巨噬细胞介导的针对牛艾美球虫的免疫反应。
Vet Parasitol. 2009 Oct 14;164(2-4):141-53. doi: 10.1016/j.vetpar.2009.06.003. Epub 2009 Jun 11.
10
TNF-α-stimulated fibroblasts secrete lumican to promote fibrocyte differentiation.肿瘤坏死因子-α刺激的成纤维细胞分泌核心蛋白聚糖以促进纤维细胞分化。
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11929-34. doi: 10.1073/pnas.1507387112. Epub 2015 Sep 8.

引用本文的文献

1
Latest updates on pathogenesis mechanisms and management strategies for cytokine release syndrome, neurotoxicity, and hemophagocytic lymphohistiocytosis related to CAR-T cell therapies.嵌合抗原受体T细胞(CAR-T)疗法相关的细胞因子释放综合征、神经毒性和噬血细胞性淋巴组织细胞增生症的发病机制及管理策略的最新进展
Ann Hematol. 2025 Jun 19. doi: 10.1007/s00277-025-06467-y.
2
Cryptococcosis Associated With Biologic Therapy: A Narrative Review.生物治疗相关的隐球菌病:一篇叙述性综述。
Open Forum Infect Dis. 2024 Jun 26;11(7):ofae316. doi: 10.1093/ofid/ofae316. eCollection 2024 Jul.
3
An updated portrait of monocyte-macrophages in classical Hodgkin lymphoma.

本文引用的文献

1
CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton's tyrosine kinase.B细胞慢性淋巴细胞白血病细胞中CXCR4和BCR触发的整合素激活依赖于JAK2激活的布鲁顿酪氨酸激酶。
Oncotarget. 2018 Oct 12;9(80):35123-35140. doi: 10.18632/oncotarget.26212.
2
Ibrutinib suppresses LPS-induced neuroinflammatory responses in BV2 microglial cells and wild-type mice.伊布替尼抑制 LPS 诱导的 BV2 小胶质细胞和野生型小鼠的神经炎症反应。
J Neuroinflammation. 2018 Sep 19;15(1):271. doi: 10.1186/s12974-018-1308-0.
3
Ibrutinib and fungus: an invasive concern.
经典型霍奇金淋巴瘤中单核细胞-巨噬细胞的最新描述
Front Oncol. 2023 Feb 24;13:1149616. doi: 10.3389/fonc.2023.1149616. eCollection 2023.
4
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies.嵌合抗原受体 T 细胞疗法的细胞因子释放综合征和神经毒性的机制及相关预防和管理策略。
J Exp Clin Cancer Res. 2021 Nov 18;40(1):367. doi: 10.1186/s13046-021-02148-6.
5
Restoration of the immune function as a complementary strategy to treat Chronic Lymphocytic Leukemia effectively.将免疫功能恢复作为有效治疗慢性淋巴细胞白血病的补充策略。
J Exp Clin Cancer Res. 2021 Oct 15;40(1):321. doi: 10.1186/s13046-021-02115-1.
6
Multifaceted Immunomodulatory Effects of the BTK Inhibitors Ibrutinib and Acalabrutinib on Different Immune Cell Subsets - Beyond B Lymphocytes.布鲁顿酪氨酸激酶(BTK)抑制剂依鲁替尼和阿卡拉布替尼对不同免疫细胞亚群的多方面免疫调节作用——超越B淋巴细胞。
Front Cell Dev Biol. 2021 Aug 13;9:727531. doi: 10.3389/fcell.2021.727531. eCollection 2021.
7
in Patients with Lymphoid Neoplasms: An Illustration of Evolutive Host-Fungus Interactions.在淋巴肿瘤患者中:宿主与真菌进化性相互作用的例证
J Fungi (Basel). 2021 Mar 16;7(3):212. doi: 10.3390/jof7030212.
8
Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure.伊布替尼治疗失败后靶向 CD19 的嵌合抗原受体 T 细胞与伊布替尼联合治疗慢性淋巴细胞白血病的可行性和疗效。
Blood. 2020 May 7;135(19):1650-1660. doi: 10.1182/blood.2019002936.
依鲁替尼与真菌:一个侵袭性问题。
Blood. 2018 Apr 26;131(17):1882-1884. doi: 10.1182/blood-2018-02-832154.
4
PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer.PTX3,一种体液模式识别分子,参与固有免疫、组织修复和癌症。
Physiol Rev. 2018 Apr 1;98(2):623-639. doi: 10.1152/physrev.00016.2017.
5
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.依鲁替尼对原发性中枢神经系统淋巴瘤中B细胞受体信号传导的抑制作用
Cancer Cell. 2017 Jun 12;31(6):833-843.e5. doi: 10.1016/j.ccell.2017.04.012. Epub 2017 May 25.
6
Invasive aspergillosis related to ibrutinib therapy for chronic lymphocytic leukemia.与依鲁替尼治疗慢性淋巴细胞白血病相关的侵袭性曲霉病
Respir Med Case Rep. 2017 Mar 20;21:27-29. doi: 10.1016/j.rmcr.2017.03.011. eCollection 2017.
7
Social network architecture of human immune cells unveiled by quantitative proteomics.人类免疫细胞的社交网络结构通过定量蛋白质组学揭示。
Nat Immunol. 2017 May;18(5):583-593. doi: 10.1038/ni.3693. Epub 2017 Mar 6.
8
Disseminated fusarium infection after ibrutinib therapy in chronic lymphocytic leukaemia.伊布替尼治疗慢性淋巴细胞白血病后发生播散性镰刀菌感染。
Ann Hematol. 2017 May;96(5):871-872. doi: 10.1007/s00277-017-2944-7. Epub 2017 Feb 9.
9
Severe pneumonia associated with ibrutinib monotherapy for CLL and lymphoma.与依鲁替尼单药治疗慢性淋巴细胞白血病和淋巴瘤相关的重症肺炎。
Hematol Oncol. 2018 Feb;36(1):349-354. doi: 10.1002/hon.2387. Epub 2017 Feb 3.
10
The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation.布鲁顿酪氨酸激酶抑制剂依鲁替尼可消除髓系细胞触发受体1介导的中性粒细胞活化。
Haematologica. 2017 May;102(5):e191-e194. doi: 10.3324/haematol.2016.152017. Epub 2017 Jan 25.